US4920214A
(en)
*
|
1986-04-16 |
1990-04-24 |
American Maize-Products Company |
Process for producing modified cyclodextrins
|
JPH0819004B2
(ja)
*
|
1986-12-26 |
1996-02-28 |
日清製粉株式会社 |
徐放性医薬製剤
|
IT1203968B
(it)
*
|
1987-04-24 |
1989-02-23 |
Bononi Ricerca |
Complessi di b-ciclodestrina ad attivita' antimicotica
|
NZ224497A
(en)
*
|
1987-05-18 |
1990-04-26 |
Janssen Pharmaceutica Nv |
Pharmaceutical composition comprising flunarizine
|
JP2577049B2
(ja)
*
|
1987-06-04 |
1997-01-29 |
三共株式会社 |
シクロスポリン製剤
|
NZ225045A
(en)
*
|
1987-07-01 |
1990-06-26 |
Janssen Pharmaceutica Nv |
Antiviral pharmaceutical compositions containing cyclodextrin and an antiviral agent
|
ZA884592B
(en)
*
|
1987-08-31 |
1989-03-29 |
Warner Lambert Co |
Cyclodextrin complexes of bis-biguanido hexane compounds
|
US4877774A
(en)
*
|
1987-09-09 |
1989-10-31 |
The United States Of America As Represented By The Department Of Health And Human Services |
Administration of steroid hormones
|
US5256652A
(en)
*
|
1987-11-12 |
1993-10-26 |
Pharmedic Co. |
Topical compositions and methods for treatment of male impotence
|
BE1001704A3
(fr)
*
|
1987-12-22 |
1990-02-13 |
Glaxo Group Ltd |
Compositions aqueuses contenant un derive de l'acide piperidinylcyclopentylheptenoique.
|
US5221695A
(en)
*
|
1987-12-22 |
1993-06-22 |
Glaxo Group Limited |
Aqueous formulation containing a piperidinylcyclopentylheptenoic acid derivative and beta-cyclodextrin
|
US5002935A
(en)
*
|
1987-12-30 |
1991-03-26 |
University Of Florida |
Improvements in redox systems for brain-targeted drug delivery
|
US5017566A
(en)
*
|
1987-12-30 |
1991-05-21 |
University Of Florida |
Redox systems for brain-targeted drug delivery
|
EP0326196B1
(en)
*
|
1988-01-14 |
1992-03-25 |
Akzo N.V. |
Aqueous pharmaceutical preparation
|
US5760015A
(en)
*
|
1988-01-19 |
1998-06-02 |
The Trustees Of The University Of Pennsylvania |
Cyclodextrin compounds and methods of making and use thereof
|
DE68910113T2
(de)
*
|
1988-01-19 |
1994-03-17 |
Childrens Hospital Corp |
Wachstuminhibierendes mittel und dessen verwendung.
|
US5658894A
(en)
*
|
1989-04-23 |
1997-08-19 |
The Trustees Of The University Of Pennsylvania |
Compositions for inhibiting restenosis
|
US5637575A
(en)
*
|
1988-01-19 |
1997-06-10 |
The Trustees Of The University Of Pennsylvania |
Methods of inhibiting restenosis
|
AU626538B2
(en)
*
|
1988-01-19 |
1992-08-06 |
Moses Judah Folkman |
Growth inhibiting agent and the use thereof
|
US5019562A
(en)
*
|
1988-01-19 |
1991-05-28 |
The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation |
Growth inhibiting agent and the use thereof
|
DE3809808A1
(de)
*
|
1988-03-23 |
1989-10-05 |
Hexal Pharma Gmbh & Co Kg |
Feste, insbesondere festorale und rektale, etofenamat enthaltende arzneimittel
|
US5236944A
(en)
*
|
1988-03-28 |
1993-08-17 |
Janssen Pharmaceutica N.V. |
Compounds, compositions and anti-neoplastic methods
|
DE3815902A1
(de)
*
|
1988-05-10 |
1989-11-23 |
Schwarz Pharma Gmbh |
Einschlussverbindungen des 1-(4-(2-(5-chloro-2-methoxybenzamido)ethyl) -phenylsulfonyl)-3-cyclohexylharnstoffs mit (alpha)-,ss-,(gamma)-cyclodextrinen, jeweils diese enthaltendes pharmazeutisches praeparat und verfahren zu deren herstellung
|
GB8813682D0
(en)
*
|
1988-06-09 |
1988-07-13 |
Reckitt & Colmann Prod Ltd |
Pharmaceutical compositions
|
NL8801670A
(nl)
|
1988-07-01 |
1990-02-01 |
Walter Adrianus Josephus Johan |
Farmaceutisch preparaat.
|
US5229370A
(en)
*
|
1988-08-15 |
1993-07-20 |
Ammeraal Robert N |
Water soluble branched beta cyclodextrin steroid complex
|
EP0381747A4
(en)
*
|
1988-08-15 |
1991-09-11 |
American Maize-Products Company |
Water soluble branched beta cyclodextrin steroid complex
|
MY106598A
(en)
*
|
1988-08-31 |
1995-06-30 |
Australian Commercial Res & Development Ltd |
Compositions and methods for drug delivery and chromatography.
|
US5997856A
(en)
*
|
1988-10-05 |
1999-12-07 |
Chiron Corporation |
Method and compositions for solubilization and stabilization of polypeptides, especially proteins
|
JP2929108B2
(ja)
*
|
1988-10-28 |
1999-08-03 |
株式会社資生堂 |
化粧料および粉末化粧料
|
AU616571B2
(en)
*
|
1988-10-28 |
1991-10-31 |
Shiseido Company Ltd. |
Cosmetic composition containing inclusion product with hydroxyalkylated cyclodextrin
|
IT1227626B
(it)
*
|
1988-11-28 |
1991-04-23 |
Vectorpharma Int |
Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
|
US5441944A
(en)
*
|
1989-04-23 |
1995-08-15 |
The Trustees Of The University Of Pennsylvania |
Substituted cyclodextrin sulfates and their uses as growth modulating agents
|
GB8910069D0
(en)
*
|
1989-05-03 |
1989-06-21 |
Janssen Pharmaceutica Nv |
Method of topically treating acne vulgaris
|
JPH0737390B2
(ja)
*
|
1989-08-29 |
1995-04-26 |
久光製薬株式会社 |
軟膏組成物
|
EP0491812A4
(en)
*
|
1989-09-14 |
1992-11-04 |
Australian Commercial Research & Development Limited |
Drug delivery compositions
|
US5053240A
(en)
*
|
1989-10-24 |
1991-10-01 |
Kalamazoo Holdings, Inc. |
Norbixin adducts with water-soluble or water-dispersible proteins or branched-chain or cyclic polysaccharides
|
GB9001987D0
(en)
*
|
1990-01-29 |
1990-03-28 |
Janssen Pharmaceutica Nv |
Improved cyclodextrin based erythropietin formulation
|
EP0518930A4
(en)
*
|
1990-03-02 |
1993-09-15 |
Australian Commercial Research & Development Limited |
Cyclodextrin compositions and methods for pharmaceutical and industrial applications
|
FR2660309B1
(fr)
*
|
1990-03-27 |
1992-07-17 |
Roussel Uclaf |
Nouveaux complexes de l'acide tiaprofenique ou de ses esters insolubles ou partiellement solubles avec les cyclodextrines ou leurs derives.
|
JP2867162B2
(ja)
*
|
1990-03-31 |
1999-03-08 |
株式会社資生堂 |
ピールオフ型パック化粧料
|
US5124154A
(en)
*
|
1990-06-12 |
1992-06-23 |
Insite Vision Incorporated |
Aminosteroids for ophthalmic use
|
US5120720A
(en)
*
|
1990-09-20 |
1992-06-09 |
The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services |
Preparation of lipophile:hydroxypropylcyclodextrin complexes by a method using co-solubilizers
|
LU87843A1
(fr)
*
|
1990-11-15 |
1992-08-25 |
Cird Galderma |
Gel aqueux a base d'acide retinoique et d'hydroxypropyl-beta-cyclodextrine et son utilisation en medecine humaine et en cosmetique
|
JPH04351603A
(ja)
*
|
1991-05-29 |
1992-12-07 |
Toppan Printing Co Ltd |
β−シクロデキストリン誘導体
|
DE69231457T2
(de)
*
|
1991-06-21 |
2001-05-23 |
Takeda Chemical Industries Ltd |
Zyklodextrin-Zusammensetzung enthaltend Fumagillol-Derivate
|
US5446030A
(en)
*
|
1991-09-19 |
1995-08-29 |
Weisz; Paul B. |
Prevention of hemolysis
|
ATE156019T1
(de)
*
|
1991-10-16 |
1997-08-15 |
Schering Corp |
Lipophile zusammensetzungen von oligosaccharid- antibiotikasalzen
|
IL103558A0
(en)
|
1991-10-30 |
1993-03-15 |
Schering Corp |
Tri-substituted tetrahydrofuran antifungals
|
US5254541A
(en)
*
|
1991-11-15 |
1993-10-19 |
Merck Frosst Canada, Inc. |
(Quinolin-2-ylmethoxy)indole/cyclodextrin complex
|
DE4207922A1
(de)
*
|
1992-03-13 |
1993-09-23 |
Pharmatech Gmbh |
Wasserloesliche einschlussverbindungen und verfahren zu deren herstellung
|
US5472954A
(en)
*
|
1992-07-14 |
1995-12-05 |
Cyclops H.F. |
Cyclodextrin complexation
|
US5324718A
(en)
*
|
1992-07-14 |
1994-06-28 |
Thorsteinn Loftsson |
Cyclodextrin/drug complexation
|
DE4227569C1
(de)
*
|
1992-08-20 |
1994-06-09 |
Inst Chemo Biosensorik |
Verfahren zum empfindlichen enzymatischen Nachweis von anorganischem Phosphat
|
TW251236B
(fi)
*
|
1992-09-10 |
1995-07-11 |
Ciba Vision Ag |
|
JP2879395B2
(ja)
*
|
1992-10-26 |
1999-04-05 |
富士写真フイルム株式会社 |
ロダシアニン化合物及びシクロデキストリンを含有する抗癌性組成物
|
US5494901A
(en)
*
|
1993-01-05 |
1996-02-27 |
Javitt; Jonathan C. |
Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent
|
CA2157190A1
(en)
*
|
1993-03-05 |
1994-09-15 |
Wilfried Fischer |
Crystalline cyclodextrin inclusion complexes of ranitidine hydrochloride and process for their preparation
|
CA2159717A1
(en)
*
|
1993-03-31 |
1994-10-13 |
Elliot Barnathan |
Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor
|
DK94093D0
(da)
*
|
1993-08-17 |
1993-08-17 |
Finn Molke Borgbjerg |
Lokalanaestetisk praeparat
|
TW349870B
(en)
*
|
1993-09-30 |
1999-01-11 |
Janssen Pharmaceutica Nv |
An antifungal pharmaceutical composition for oral administration and a process for the preparation thereof
|
RU2135176C1
(ru)
*
|
1993-12-14 |
1999-08-27 |
Эли Лилли Энд Компани |
Водорастворенный комплекс включения соединений бензотиофена с водорастворимым циклодекстрином, способ его получения и фармацевтическая композиция
|
US5646131A
(en)
*
|
1994-02-22 |
1997-07-08 |
The Arab Company For Drug Industries And Medical Applicances (Acdima) |
Method for solubilizing drugs using cyclodextrins and carboxylic acids
|
AU1716995A
(en)
*
|
1994-03-18 |
1995-10-09 |
Ciba-Geigy Ag |
Aqueous solution of levocabastine for ophthalmic use
|
DE4414138A1
(de)
*
|
1994-04-22 |
1995-10-26 |
Consortium Elektrochem Ind |
Acylierte gamma-Cyclodextrine
|
AU2531295A
(en)
*
|
1994-05-27 |
1995-12-21 |
Farmarc Nederland Bv |
Pharmaceutical composition
|
FR2726765B1
(fr)
*
|
1994-11-14 |
1996-12-20 |
Cis Bio Int |
Compositions radiopharmaceutiques comprenant un complexe d'inclusion d'une cyclodextrine et d'un acide gras radiohalogene
|
US5576311A
(en)
*
|
1994-11-30 |
1996-11-19 |
Pharmos Corporation |
Cyclodextrins as suspending agents for pharmaceutical suspensions
|
FR2735136B1
(fr)
*
|
1995-06-08 |
1997-08-14 |
Roquette Freres |
Composition pulverulente d'hydroxypropyl-betacyclodextrine et son procede de preparation.
|
JP2920611B2
(ja)
*
|
1995-12-11 |
1999-07-19 |
株式会社シーエーシー |
皮膚炎の治療外用剤
|
GB9605705D0
(en)
|
1996-03-19 |
1996-05-22 |
Pfizer Ltd |
Therapeutic agents
|
DE69733664T3
(de)
|
1996-04-19 |
2011-04-14 |
Grifols Inc. (n.d. Ges.d.Staates Delaware), Los Angeles |
Verfahren zur INaktivierung von Viren und Lyophilisierung von Blutproteinen
|
SE9601556D0
(sv)
*
|
1996-04-24 |
1996-04-24 |
Astra Ab |
New pharmaceutical formulation of a thrombin inhibitor for parenteral use
|
ES2207748T3
(es)
*
|
1996-08-09 |
2004-06-01 |
Alcon Manufacturing Ltd. |
Sistemas conservantes para composiciones farmaceuticas que contienen ciclodextrinas.
|
US5942501A
(en)
*
|
1996-08-16 |
1999-08-24 |
Collaborative Laboratories, Inc. |
Cyclodextrin derivative complex
|
EP0838225A3
(en)
*
|
1996-10-25 |
1999-03-24 |
Hiji, Yasutake |
Aqueous local anesthetic solution
|
ATE241969T1
(de)
*
|
1997-03-26 |
2003-06-15 |
Janssen Pharmaceutica Nv |
Tabletten mit einem kern, der mit einem pilzbekämpfungsmittel und einem polymeren beschichtet ist
|
GB9713149D0
(en)
|
1997-06-21 |
1997-08-27 |
Pfizer Ltd |
Pharmaceutical formulations
|
US6596706B1
(en)
|
1997-11-07 |
2003-07-22 |
Daiichi Pharmaceutical Co., Ltd. |
Piperazine-cyclodextrin complexes
|
WO1999033467A1
(en)
|
1997-12-31 |
1999-07-08 |
Choongwae Pharma Corporation |
Method and composition of an oral preparation of itraconazole
|
US6683100B2
(en)
|
1999-01-19 |
2004-01-27 |
Novartis Ag |
Organic compounds
|
US6194181B1
(en)
|
1998-02-19 |
2001-02-27 |
Novartis Ag |
Fermentative preparation process for and crystal forms of cytostatics
|
DE19848303A1
(de)
*
|
1998-10-14 |
2000-04-20 |
Schering Ag |
Kombination aus Gestagenen und Zuckern
|
GB9906126D0
(en)
*
|
1999-03-18 |
1999-05-12 |
Knoll Ag |
Pharmaceutical formulations
|
AU5975700A
(en)
*
|
1999-07-02 |
2001-01-22 |
Janssen Pharmaceutica N.V. |
Nasal formulation of an antifungal
|
SE9902988D0
(sv)
*
|
1999-08-24 |
1999-08-24 |
Astra Ab |
Chemical compounds
|
CA2726789A1
(en)
|
2000-02-05 |
2001-11-08 |
Theravance, Inc. |
Cyclodextrin containing glycopeptide antibiotic compositions
|
US6468989B1
(en)
|
2000-07-13 |
2002-10-22 |
Dow Pharmaceutical Sciences |
Gel compositions containing metronidazole
|
PE20020300A1
(es)
|
2000-08-22 |
2002-05-10 |
Pharmacia Corp |
Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco
|
US6962944B2
(en)
|
2001-07-31 |
2005-11-08 |
Arqule, Inc. |
Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
|
US7074824B2
(en)
|
2001-07-31 |
2006-07-11 |
Arqule, Inc. |
Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
|
US6982256B2
(en)
|
2001-09-07 |
2006-01-03 |
Boehringer Ingelheim Pharma Kg |
Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration
|
WO2003033025A2
(en)
|
2001-10-18 |
2003-04-24 |
Decode Genetics Ehf |
Cyclodextrin complexes
|
GB0127677D0
(en)
*
|
2001-11-19 |
2002-01-09 |
Vianex S A |
Inclusion complex
|
US6881726B2
(en)
|
2001-12-24 |
2005-04-19 |
Dow Pharmaceutical Sciences |
Aqueous compositions containing metronidazole
|
AR038575A1
(es)
|
2002-02-22 |
2005-01-19 |
Pharmacia Corp |
Formulacion oftalmica con nueva composicion de goma
|
US6951846B2
(en)
*
|
2002-03-07 |
2005-10-04 |
The United States Of America As Represented By The Secretary Of The Army |
Artemisinins with improved stability and bioavailability for therapeutic drug development and application
|
US6818662B2
(en)
|
2002-05-28 |
2004-11-16 |
Taisho Pharmaceutical Co., Ltd. |
Pharmaceutical composition
|
DE10228049A1
(de)
*
|
2002-06-24 |
2004-01-15 |
Merck Patent Gmbh |
Flüssige Zubereitung enthaltend Oligopeptide
|
MXPA05010330A
(es)
|
2003-03-28 |
2006-05-31 |
Ivax Corp |
Formulaciones de cladribina para el mejor suministro oral y a traves de la mucosa.
|
PT1608344E
(pt)
|
2003-03-28 |
2010-09-02 |
Ares Trading Sa |
Formulações orais de cladribina
|
UA81305C2
(en)
|
2003-07-02 |
2007-12-25 |
Ares Trading Sa |
Formulation of cladribine (variants), cladribine-cyclodextrin complex, use of cladribine-cyclodextrin complex, mixture
|
CN1294912C
(zh)
*
|
2004-03-01 |
2007-01-17 |
上海医药工业研究院 |
伊曲康唑盐酸盐组合物及其冻干粉针
|
DE102004011512B4
(de)
|
2004-03-08 |
2022-01-13 |
Boehringer Ingelheim Vetmedica Gmbh |
Pharmazeutische Zubereitung enthaltend Pimobendan
|
US8980894B2
(en)
|
2004-03-25 |
2015-03-17 |
Boehringer Ingelheim Vetmedica Gmbh |
Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
|
EP1579862A1
(en)
|
2004-03-25 |
2005-09-28 |
Boehringer Ingelheim Vetmedica Gmbh |
Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
|
ITMI20041763A1
(it)
*
|
2004-09-16 |
2004-12-16 |
Altergon Sa |
Nuove formulazioni iniettabili contenenti progesterone
|
WO2006137433A1
(ja)
*
|
2005-06-21 |
2006-12-28 |
Wakamoto Pharmaceutical Co., Ltd. |
レボカバスチンを可溶化させた水性薬剤
|
US7744904B1
(en)
|
2005-09-26 |
2010-06-29 |
B.B. Scientific L.L.C. |
Stabilization of Clostridium botulinum neurotoxin complex
|
PT2054040E
(pt)
|
2006-08-16 |
2011-06-30 |
Novartis Ag |
Método para produzir dispersões sólidas de compostos terapêuticos altamente cristalinos
|
MX2009004214A
(es)
*
|
2006-10-20 |
2009-05-11 |
Icos Corp |
Composiciones de inhibidores de chk1.
|
EP1920785A1
(en)
|
2006-11-07 |
2008-05-14 |
Boehringer Ingelheim Vetmedica Gmbh |
Liquid preparation comprising a complex of pimobendan and cyclodextrin
|
MX2009005368A
(es)
*
|
2006-11-21 |
2009-06-05 |
Novartis Ag |
Formulacion parenteral estable que contiene un inhibidor de rsv de una estructura de benzodiazepina.
|
CL2009000453A1
(es)
*
|
2008-02-28 |
2010-08-13 |
Takeda Pharmaceuticals Co |
Composicion farmaceutica que comprende i) compuesto derivado triciclico nitrogenado, tal como pirido[2,3-b]indol, ii) al menos un derivado de ciclodextrina y iii) agua, util para prevenir o tratar cancer e inflamacion, entre otras; metodo para mejorar la solubilidad y estabilidad en agua de dichos compuestos.
|
ES2436716T3
(es)
|
2008-11-25 |
2014-01-03 |
Boehringer Ingelheim Vetmedica Gmbh |
Pimobendan para uso en el tratamiento de la cardiomiopatía hipertrófica en gatos
|
WO2010088924A1
(en)
|
2009-02-06 |
2010-08-12 |
Telormedix Sa |
Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
|
CN102499909B
(zh)
*
|
2011-12-27 |
2013-08-07 |
哈尔滨三联药业有限公司 |
伊曲康唑分散片及其制备方法
|
KR101383941B1
(ko)
*
|
2012-03-09 |
2014-04-10 |
동아에스티 주식회사 |
피록시캄 또는 약제학적으로 허용되는 그의 염과 히알루론산 또는 약제학적으로 허용되는 그의 염의 안정한 액상 조성물 및 그 제조방법
|
ES2924478T3
(es)
|
2012-03-15 |
2022-10-07 |
Boehringer Ingelheim Vetmedica Gmbh |
Formulación de comprimidos farmacéuticos para el sector médico veterinario, método de producción y uso de los mismos
|
JP6282644B2
(ja)
*
|
2012-06-28 |
2018-02-21 |
ジヨンソン・アンド・ジヨンソン・コンシユーマー・インコーポレーテツドJohnson & Johnson Consumer Inc. |
ラセカドトリル液体組成物
|
EA201591710A1
(ru)
*
|
2013-03-13 |
2016-03-31 |
Сиэтл Дженетикс, Инк. |
Композиции, содержащие циклодекстрин и конъюгат антитело-лекарственное средство
|
CN105377235A
(zh)
|
2013-07-19 |
2016-03-02 |
勃林格殷格翰动物保健有限公司 |
含有防腐的醚化的环糊精衍生物的液体水性药物组合物
|
WO2015054429A1
(en)
*
|
2013-10-08 |
2015-04-16 |
Innopharma, Inc |
Aprepitant oral liquid formulations
|
BR112016011111B1
(pt)
|
2013-12-04 |
2022-11-16 |
Boehringer Ingelheim Vetmedica Gmbh |
Composições farmacêuticas aprimoradas de pimobendan
|
US10537570B2
(en)
|
2016-04-06 |
2020-01-21 |
Boehringer Ingelheim Vetmedica Gmbh |
Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
|
SG11201913008TA
(en)
*
|
2017-06-30 |
2020-01-30 |
Celgene Corp |
Compositions and methods of use of 2-(4-chlorophenyl)-n-((2-(2,6-doxopiperidin-3-yl)-1-oxoisoindolin-5-yl) methyl) -2,2-difluoroacetamide
|
US10716774B1
(en)
|
2018-01-05 |
2020-07-21 |
Yale Pharmaceuticals LLC |
Pharmaceutical compositions containing isotretinoin with improved dissolution profile and enhanced stability
|
CN112334494A
(zh)
*
|
2018-06-29 |
2021-02-05 |
罗盖特公司 |
新颖的羟丙基-β-环糊精及其生产方法
|
FR3083234B1
(fr)
*
|
2018-06-29 |
2020-11-27 |
Roquette Freres |
Nouvelles hydroxypropyl-beta-cyclodextrines et leurs procedes de preparation
|
BR112021008139A2
(pt)
|
2018-10-29 |
2021-08-03 |
Cyclo Therapeutics, Inc. |
métodos para tratar doença de alzheimer
|
CN114195733B
(zh)
*
|
2022-01-07 |
2024-10-01 |
华东理工大学 |
一种抑制烯丙苯噻唑异构化的方法
|